Breathing and qigong: a drug-free approach to easier breathing for damaged lungs?

NCT ID NCT07725991

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial tests whether combining resonant breathing (slow, paced breathing) with Qigong exercises can improve lung function, reduce shortness of breath, and boost quality of life in adults aged 40–65 with bronchiectasis, a chronic lung condition. Participants are randomly assigned to either resonant breathing alone or resonant breathing plus Qigong for three weeks. The study measures changes in lung function, breathlessness, and quality of life using standard questionnaires and spirometry.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Resonant breathing and Qigong exercises
What this could lead to
If effective, this combination of breathing techniques and gentle movement could offer a low-cost, drug-free way to improve breathing and daily life for people with bronchiectasis.
What could go wrong
This is a small, early-stage trial with only 46 participants over 3 weeks, so results may not apply broadly. The exercises require regular participation and may not help everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

46 people

The number who actually took part.

Started

Dec 2025

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 40 to 65 years * Both male and female participants * Diagnosed with bronchiectasis confirmed by clinical and radiological findings * Clinically stable for at least 4 weeks (no acute exacerbation) * Willing and able to participate in breathing and/or Qigong exercise sessions regularly for 3 weeks Exclusion Criteria: * Individuals who have experienced a recent flare-up of bronchiectasis in the last month. * Patients with serious heart, muscle, or nerve disorders that restrict movement * Participants already enrolled in other respiratory therapy programs. * Those with mental or communication difficulties preventing proper participation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bronchiectasis adult are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Riphah International University

    Sheikhupura, Punjab Province, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.